Evidence map›Paper›PMID 32324168›Full record

ArticleJCI insight2020

Phenotypic and functional translation of IL1RL1 locus polymorphisms in lung tissue and asthmatic airway epithelium.

Michael A Portelli, F Nicole Dijk, Maria E Ketelaar, Nick Shrine, Jenny Hankinson, Sangita Bhaker, Néomi S Grotenboer, Ma'en Obeidat, Amanda P Henry, Charlotte K Billington and 33 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Targeting alarmins in asthma: From bench to clinic.The Journal of allergy and clinical immunology · 2025
    Review
  6. Epithelial Interleukin-1 Receptor-Like-1 Activation Is Contingent on Interleukin-33 Isoforms and Asthma-Related Receptor Variation.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD.European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors at 15 institutions in 5 countries.

Michael A PortelliDivision of Respiratory Medicine, NIHR, Nottingham Biomedical Research Centre, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.
F Nicole DijkDepartment of Pediatric Pulmonology and Pediatric Allergology, and.
Maria E KetelaarDivision of Respiratory Medicine, NIHR, Nottingham Biomedical Research Centre, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.
Nick ShrineDepartment of Health Sciences, University of Leicester, Leicester, United Kingdom.
Jenny HankinsonManchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom.
Sangita BhakerDivision of Respiratory Medicine, NIHR, Nottingham Biomedical Research Centre, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.
Néomi S GrotenboerDepartment of Pediatric Pulmonology and Pediatric Allergology, and.
Ma'en ObeidatThe University of British Columbia Center for Heart Lung Innovation, St. Paul's Hospital Vancouver, Vancouver, British Columbia, Canada.
Amanda P HenryDivision of Respiratory Medicine, NIHR, Nottingham Biomedical Research Centre, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.
Charlotte K BillingtonDivision of Respiratory Medicine, NIHR, Nottingham Biomedical Research Centre, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.
Dominick ShawDivision of Respiratory Medicine, NIHR, Nottingham Biomedical Research Centre, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.
Simon R JohnsonDivision of Respiratory Medicine, NIHR, Nottingham Biomedical Research Centre, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.
Zara Ek PogsonDivision of Epidemiology and Public Health, University of Nottingham, Nottingham, United Kingdom.
Andrew FogartyDivision of Epidemiology and Public Health, University of Nottingham, Nottingham, United Kingdom.
Tricia M McKeeverDivision of Epidemiology and Public Health, University of Nottingham, Nottingham, United Kingdom.
David C NickleDepartments of Genetics and Pharmacogenomics, Merck Research Laboratories, Boston, Massachusetts, USA.
Yohan BosséInstitut universitaire de cardiologie et de pneumologie de Québec, Department of Molecular Medicine, Laval University, Québec, Canada.
Maarten van den BergeUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Department of Pulmonary Diseases, and.
Alen FaizUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Department of Pulmonary Diseases, and.
Sharon BrouwerDepartment of Pathology and Medical Biology, Beatrix Children's Hospital, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, University of Groningen, Groningen, Netherlands.
Judith M VonkDepartment of Epidemiology, Beatrix Children's Hospital, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, University of Groningen, Groningen, Netherlands.
Paul de VosDepartment of Pathology and Medical Biology, Beatrix Children's Hospital, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, University of Groningen, Groningen, Netherlands.
Corry-Anke BrandsmaDepartment of Pathology and Medical Biology, Beatrix Children's Hospital, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, University of Groningen, Groningen, Netherlands.
Cornelis J VermeulenDepartment of Pathology and Medical Biology, Beatrix Children's Hospital, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, University of Groningen, Groningen, Netherlands.
Amisha SingapuriRespiratory sciences, University of Leicester, Glenfield Hospital, Leicester, United Kingdom.
Liam G HeaneyCentre for Experimental Medicine, Queens University of Belfast, Belfast, United Kingdom.
Adel H MansurDepartment of Respiratory Medicine, Birmingham Heartlands Hospital and University of Birmingham, Birmingham, United Kingdom.
Rekha ChaudhuriInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Neil C ThomsonInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
John W HollowayDepartment of Human Development and.
Gabrielle A LockettDepartment of Human Development and.
Peter H HowarthDepartment of Human Development and.
Robert NivenManchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom.
Angela SimpsonManchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom.
John D BlakeyRespiratory Medicine, Sir Charles Gairdner Hospital, Perth, Australia.
Martin D TobinDepartment of Health Sciences, University of Leicester, Leicester, United Kingdom.
Dirkje S PostmaUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Department of Pulmonary Diseases, and.
Ian P HallDivision of Respiratory Medicine, NIHR, Nottingham Biomedical Research Centre, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.
Louise V WainDepartment of Health Sciences, University of Leicester, Leicester, United Kingdom.
Martijn C NawijnDepartment of Pathology and Medical Biology, Beatrix Children's Hospital, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, University of Groningen, Groningen, Netherlands.
Christopher E BrightlingRespiratory sciences, University of Leicester, Glenfield Hospital, Leicester, United Kingdom.
Gerard H KoppelmanDepartment of Pediatric Pulmonology and Pediatric Allergology, and.
Ian SayersDivision of Respiratory Medicine, NIHR, Nottingham Biomedical Research Centre, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.
University Medical Center Groningen · NLNottingham Biomedical Research Centre · GBManchester Academic Health Science Centre · GBNIHR Southampton Respiratory Biomedical Research Unit · GBUniversity of Leicester · GBUniversity of Nottingham · GBGlenfield Hospital · GBPulmonary and Allergy Associates · USUniversity of Glasgow · GBHeartlands Hospital · GBInstitut universitaire de cardiologie et de pneumologie de Québec · CAMerck & Co., Inc., Rahway, NJ, USA (United States) · USQueen's University Belfast · GBSir Charles Gairdner Hospital · AUSt. Paul's Hospital · CA

Funding

Medical Research Council G0601361Medical Research Council G1000861Medical Research Council G1100163Medical Research Council MC_PC_12010Medical Research Council MR/K002449/1Medical Research Council MR/L012693/1
6 · The paper itself

Abstract

The IL1RL1 (ST2) gene locus is robustly associated with asthma; however, the contribution of single nucleotide polymorphisms (SNPs) in this locus to specific asthma subtypes and the functional mechanisms underlying these associations remain to be defined. We tested for association between IL1RL1 region SNPs and characteristics of asthma as defined by clinical and immunological measures and addressed functional effects of these genetic variants in lung tissue and airway epithelium. Utilizing 4 independent cohorts (Lifelines, Dutch Asthma GWAS [DAG], Genetics of Asthma Severity and Phenotypes [GASP], and Manchester Asthma and Allergy Study [MAAS]) and resequencing data, we identified 3 key signals associated with asthma features. Investigations in lung tissue and primary bronchial epithelial cells identified context-dependent relationships between the signals and IL1RL1 mRNA and soluble protein expression. This was also observed for asthma-associated IL1RL1 nonsynonymous coding TIR domain SNPs. Bronchial epithelial cell cultures from asthma patients, exposed to exacerbation-relevant stimulations, revealed modulatory effects for all 4 signals on IL1RL1 mRNA and/or protein expression, suggesting SNP-environment interactions. The IL1RL1 TIR signaling domain haplotype affected IL-33-driven NF-κB signaling, while not interfering with TLR signaling. In summary, we identify that IL1RL1 genetic signals potentially contribute to severe and eosinophilic phenotypes in asthma, as well as provide initial mechanistic insight, including genetic regulation of IL1RL1 isoform expression and receptor signaling.

Indexed as

AsthmaGenetic Predisposition to DiseaseGenotypeHumansInterleukin-1 Receptor-Like 1 ProteinLungPhenotypePolymorphism, Single NucleotideRespiratory MucosaIL1RL1 protein, humanInterleukin-1 Receptor-Like 1 ProteinAsthmaCell BiologyGeneticsGenetic variationMolecular genetics

Identifiers

PMID32324168
PMCPMC7205441
OpenAlexW3015651558

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.